Yokukansan Appears to Regulate Epidermal Glutamate Signaling, Notably NMDA Receptors, in the Epidermis

*1)Department of Dermatology, Juntendo University Faculty of Medicine, Tokyo, Japan, *2)Funakushi Dermatology clinic, Saitama, Japan, *3) Tsumura Research Laboratories, Tsumura & Co, Ibaraki, Japan, *4) Center for Advanced Kampo Medical and Clinical Research, Juntendo University Faculty of Medicine, Tokyo, Japan, *5) Atopy (Allergy) Research Center, Juntendo University Faculty of Medicine, Tokyo, Japan, *6)Dermatology Unit, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan

[1]  S. Kanba,et al.  Anti‐allergic mechanisms of Japanese herbal medicine, yokukansan on mast cells , 2014, The Journal of dermatology.

[2]  若林 満貴.  Yokukansan, a Traditional Japanese Medicine, Adjusts Glutamate Signaling in Cultured Keratinocytes , 2014 .

[3]  E. Hinoi,et al.  [Glutamate signaling in non-neuronal tissues]. , 2012, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[4]  H. Suto,et al.  Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice , 2011, Archives of Dermatological Research.

[5]  S. Kawana,et al.  Efficacy of a 5‐HT1a receptor agonist in atopic dermatitis , 2010, Clinical and experimental dermatology.

[6]  K. Kullander,et al.  VGLUT2-Dependent Sensory Neurons in the TRPV1 Population Regulate Pain and Itch , 2010, Neuron.

[7]  M. Tohyama,et al.  Yokukansan Inhibits Neuronal Death during ER Stress by Regulating the Unfolded Protein Response , 2010, PloS one.

[8]  K. Takeuchi,et al.  Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  N. Hattori,et al.  Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  K. Sekiguchi,et al.  Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells. , 2010, Journal of ethnopharmacology.

[11]  H. Shinno,et al.  Successful treatment of restless legs syndrome with the herbal prescription Yokukansan , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  Y. Kase,et al.  Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes. , 2010, European journal of pharmacology.

[13]  M. Ishii,et al.  Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study , 2008, Evidence-based complementary and alternative medicine : eCAM.

[14]  H. Suto,et al.  Erratum to “Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice” [J. Dermatol. Sci. 56 (2009) 37–42] , 2009 .

[15]  H. Suto,et al.  Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice. , 2009, Journal of dermatological science.

[16]  Yoshitaka Nakamura,et al.  [Efficacy of traditional herbal medicine, Yokukansan on patients with neuropathic pain]. , 2009, Masui. The Japanese journal of anesthesiology.

[17]  K. Sekiguchi,et al.  Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats. , 2009, Biological & pharmaceutical bulletin.

[18]  M. Ohtsuki,et al.  Guidelines for management of atopic dermatitis , 2009, The Journal of dermatology.

[19]  Jamie D. Feusner,et al.  The Mouse Who Couldn't Stop Washing: Pathologic Grooming in Animals and Humans , 2009, CNS Spectrums.

[20]  T. Ueki,et al.  Neuroprotective effects of yokukansan, a traditional japanese medicine, on glutamate-mediated excitotoxicity in cultured cells , 2009, Neuroscience.

[21]  Ayumi Ishibashi,et al.  Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents. , 2009, Biological & pharmaceutical bulletin.

[22]  H. Arai,et al.  Traditional Chinese medicine on four patients with Huntington's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[23]  M. Furuya,et al.  Yi-Gan San as Adjunctive Therapy for Treatment-Resistant Schizophrenia: An Open-Label Study , 2009, Clinical neuropharmacology.

[24]  A. Holmes,et al.  Loss of Glial Glutamate and Aspartate Transporter (Excitatory Amino Acid Transporter 1) Causes Locomotor Hyperactivity and Exaggerated Responses to Psychotomimetics: Rescue by Haloperidol and Metabotropic Glutamate 2/3 Agonist , 2008, Biological Psychiatry.

[25]  Ayumi Ishibashi,et al.  Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[26]  H. Suto,et al.  Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice. , 2007, Journal of dermatological science.

[27]  S. Dudek,et al.  Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice , 2007, Nature.

[28]  S. Nakaike,et al.  Involvement of IL‐31 on scratching behavior in NC/Nga mice with atopic‐like dermatitis , 2006, Experimental dermatology.

[29]  H. Arai,et al.  Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. , 2005, The Journal of clinical psychiatry.

[30]  Hiroyuki Tanaka,et al.  Kampo Medicines for Mite Antigen-Induced Allergic Dermatitis in NC/Nga Mice , 2005, Evidence-based complementary and alternative medicine : eCAM.

[31]  H. Arai,et al.  A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. , 2005, The Journal of clinical psychiatry.

[32]  M. Murakami,et al.  Characterization of the expression and function of N‐methyl‐D‐aspartate receptor in keratinocytes , 2004, Experimental dermatology.

[33]  J. Wohlrab,et al.  N‐methyl‐D‐aspartate receptors influence the intracellular calcium concentration of keratinocytes , 2004, Experimental dermatology.

[34]  M. Bear,et al.  Significance of N‐methyl‐d‐aspartate (NMDA) receptor‐mediated signaling in human keratinocytes , 2004, Journal of cellular physiology.

[35]  Kaori Inoue,et al.  NMDA-type glutamate receptor is associated with cutaneous barrier homeostasis. , 2003, The Journal of investigative dermatology.

[36]  M. Gupta,et al.  Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders , 2003, American journal of clinical dermatology.

[37]  P. Genever,et al.  Glutamate signalling in non-neuronal tissues. , 2001, Trends in pharmacological sciences.

[38]  K. Hira,et al.  NC/Nga Mice: A Mouse Model for Atopic Dermatitis , 1999, International Archives of Allergy and Immunology.

[39]  P. Genever,et al.  Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. , 1999, The Journal of investigative dermatology.

[40]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.